FDA inspection
Avedro, a Glaukos Company: FDA inspection ending Feb 12, 2014
FDA inspection 867602 · Voluntary Action Indicated (VAI) · Burlington, MA
Key facts
| Inspection ID | 867602 |
|---|---|
| Firm | Avedro, a Glaukos Company |
| FEI number | 3007851054 |
| Address | 30 North Ave |
| City | Burlington |
| State | MA |
| ZIP | 01803 |
| Country | United States |
| Fiscal year | 2014 |
| Inspection end date | Feb 12, 2014 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data